Early epidemiological studies have assessed the association and clinical usefulness of inflammatory markers such as C-reactive protein, cytokines, white blood cell count, and fibrinogen with CHD, and these inflammatory mediators have been associated with adverse outcomes in patients (20, 21). Here, CRP is linked to coronary artery disorder.